ARC Centre of Excellence in Convergent Bio-Nano Science and Technology. The CoE in Convergent Bio-Nano Science &Technology comprises a multi-disciplinary team focused on research aiming to understand and control the interface of materials with biological systems. The Centre will exploit knowledge of the bio-nano interface to design materials that transport and deliver vaccines, drugs and gene therapy agents, and to design new diagnostic agents and devices. Nanomedicines are on the cusp of revol ....ARC Centre of Excellence in Convergent Bio-Nano Science and Technology. The CoE in Convergent Bio-Nano Science &Technology comprises a multi-disciplinary team focused on research aiming to understand and control the interface of materials with biological systems. The Centre will exploit knowledge of the bio-nano interface to design materials that transport and deliver vaccines, drugs and gene therapy agents, and to design new diagnostic agents and devices. Nanomedicines are on the cusp of revolutionizing diagnosis and therapy in many diseases. The CoE will be the focus of bio-nano research activity in Australia, uniting universities, research agencies, institutes and companies. The expected outcomes are better diagnostic and therapeutic tools designed via an enhanced understanding of the bio-nano-interface.Read moreRead less
Pharmacological probes to facilitate preclinical development of modulators of a6 subunit containing nicotinic acetylcholine receptors. Allosteric modulators of alpha7 nicotinic acetylcholine receptors have a promising future as drugs targeting attention deficits in Alzheimer’s disease and schizophrenia but the mechanisms underlying modulation are poorly understood. This project aims to determine its binding site and develop a radioactive labelled compound that competes with its binding. The radi ....Pharmacological probes to facilitate preclinical development of modulators of a6 subunit containing nicotinic acetylcholine receptors. Allosteric modulators of alpha7 nicotinic acetylcholine receptors have a promising future as drugs targeting attention deficits in Alzheimer’s disease and schizophrenia but the mechanisms underlying modulation are poorly understood. This project aims to determine its binding site and develop a radioactive labelled compound that competes with its binding. The radiolabelled compound and a deeper insight into the mode of action will enable development of ligands for positron emission tomography (PET) which will aid in the development of BNC375 as well as other alpha7 modulators.Read moreRead less
Engineering the next generation of scaffolds. Engineering the next generation of scaffolds. This project aims to develop high efficiency quantum dots based on carbon nanomaterials, integrated with scaffolds and viable tissue cells, which can be used to develop smart implants with monitoring capabilities to reduce patient trauma and expenses. In certain cases, more than 50% of medical implants fail. Improving effective intervention is urgently needed, particularly monitoring of implants and early ....Engineering the next generation of scaffolds. Engineering the next generation of scaffolds. This project aims to develop high efficiency quantum dots based on carbon nanomaterials, integrated with scaffolds and viable tissue cells, which can be used to develop smart implants with monitoring capabilities to reduce patient trauma and expenses. In certain cases, more than 50% of medical implants fail. Improving effective intervention is urgently needed, particularly monitoring of implants and early diagnosis to prevent rejections and adverse reactions. Current methods are inefficient, expensive, and induce toxicity. A non-toxic and non-invasive method to monitor the progress of tissue regeneration and wound healing is expected to place Australia at the forefront of developing implants.Read moreRead less